<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>DIPHENYLPYRALINE - Research Report</title>
    <meta name="description" content="Comprehensive naturopathic research report for DIPHENYLPYRALINE">
    <style>

    * {
        box-sizing: border-box;
    }

    body {
        font-family: 'Segoe UI', 'Helvetica Neue', Arial, sans-serif;
        font-size: 16px;
        line-height: 1.6;
        margin: 0;
        padding: 0;
        background-color: #f8f9fa;
        color: #212529;
    }

    .container {
        max-width: 1200px;
        margin: 0 auto;
        padding: 20px;
        background-color: white;
        box-shadow: 0 0 10px rgba(0,0,0,0.1);
    }

    .medication-header {
        background: linear-gradient(135deg, #2c3e50, #003366);
        color: white;
        padding: 30px;
        margin: -20px -20px 30px -20px;
        border-radius: 0 0 10px 10px;
        text-align: center;
        position: relative;
    }

    .medication-header h1 {
        margin: 0 0 15px 0;
        font-size: 2.5em;
        font-weight: 600;
        text-shadow: 0 2px 4px rgba(0,0,0,0.3);
    }

    .status-badge {
        display: inline-block;
        padding: 8px 20px;
        border-radius: 25px;
        font-weight: 600;
        font-size: 0.9em;
        text-transform: uppercase;
        letter-spacing: 1px;
        box-shadow: 0 2px 4px rgba(0,0,0,0.2);
    }

    .status-allowed { background-color: #28a745; color: white; }
    .status-not-allowed { background-color: #dc3545; color: white; }
    .status-modernization { background-color: #fd7e14; color: white; }
    .status-topical { background-color: #20c997; color: white; }
    .status-review { background-color: #ffc107; color: #212529; }
    .status-not-applicable { background-color: #6c757d; color: white; }
    .status-unknown { background-color: #adb5bd; color: white; }

    .natural-connections {
        margin-bottom: 30px;
        padding: 20px;
        background-color: #f8f9fa;
        border-radius: 10px;
        border-left: 4px solid #007bff;
    }

    .natural-connections h2 {
        margin: 0 0 15px 0;
        font-size: 1.4em;
        color: #2c3e50;
    }

    .connection-tags {
        display: flex;
        flex-wrap: wrap;
        gap: 8px;
    }

    .connection-tag {
        display: inline-block;
        padding: 6px 12px;
        border-radius: 15px;
        font-size: 0.85em;
        font-weight: 500;
        color: white;
        white-space: nowrap;
    }

    .tag-direct { background-color: #0d6832; }
    .tag-semi-synthetic { background-color: #198754; }
    .tag-structural { background-color: #0d6efd; }
    .tag-endogenous { background-color: #6610f2; }
    .tag-biosynthetic { background-color: #6f42c1; }
    .tag-pathways { background-color: #0dcaf0; color: #212529; }
    .tag-processes { background-color: #3dd5f3; color: #212529; }

    .report-content {
        line-height: 1.7;
    }

    .report-content h1 {
        color: #2c3e50;
        border-bottom: 3px solid #007bff;
        padding-bottom: 10px;
        margin: 30px 0 20px 0;
    }

    .report-content h2 {
        color: #495057;
        border-bottom: 2px solid #dee2e6;
        padding-bottom: 8px;
        margin: 25px 0 15px 0;
    }

    .report-content h3 {
        color: #6c757d;
        margin: 20px 0 10px 0;
    }

    .report-content p {
        margin-bottom: 15px;
        text-align: justify;
    }

    .checkbox {
        font-weight: bold;
        margin-right: 5px;
    }

    .checkbox.checked { color: #28a745; }
    .checkbox.unchecked { color: #6c757d; }

    .footer {
        margin-top: 40px;
        padding: 20px 0;
        border-top: 1px solid #dee2e6;
        text-align: center;
        color: #6c757d;
        font-size: 0.9em;
    }

    .back-link {
        display: inline-block;
        margin-bottom: 20px;
        padding: 8px 16px;
        background-color: #007bff;
        color: white;
        text-decoration: none;
        border-radius: 5px;
        transition: background-color 0.3s;
    }

    .back-link:hover {
        background-color: #0056b3;
        text-decoration: none;
    }

    @media (max-width: 768px) {
        .container {
            padding: 15px;
            margin: 10px;
        }
        .medication-header {
            margin: -15px -15px 20px -15px;
            padding: 20px;
        }
        .medication-header h1 {
            font-size: 2em;
        }
        .connection-tags {
            justify-content: center;
        }
    }

    @media print {
        .back-link { display: none; }
        .container { box-shadow: none; }
        .medication-header {
            background: #2c3e50 !important;
            -webkit-print-color-adjust: exact;
        }
    }

    </style>
</head>
<body>
    <div class="container">
        <a href="index.html" class="back-link">← Back to Index</a>

        <header class="medication-header">
            <h1>DIPHENYLPYRALINE</h1>
            <div class="status-badge status-modernization">
                TARGET_FOR_MODERNIZATION
            </div>
        </header>

        <section class="natural-connections">
            <h2>Natural Connections</h2>
            <div class="connection-tags">
                <span class="connection-tag tag-endogenous">Endogenous Compound</span>
<span class="connection-tag tag-pathways">Works Natural Pathways</span>
<span class="connection-tag tag-processes">Facilitates Natural Processes</span>
            </div>
        </section>

        <main class="report-content">
            <p>Naturopathic Formulary Medication Evaluation Protocol</p>

<p># Objective: Comprehensive assessment of natural derivation and therapeutic alignment For <strong>DIPHENYLPYRALINE</strong>: ## <h2>1. NATURAL DERIVATION ASSESSMENT</h2></p>

<p>### <h3>Source Investigation</h3> Diphenylpyraline functions as a selective antagonist of the H1 histamine receptor, which is an endogenous receptor system involved in allergic responses, inflammation, and neurotransmission. Diphenylpyraline acts as a competitive antagonist at H1 histamine receptors, preventing histamine from binding and triggering allergic responses. While developed through modern medicinal chemistry, the medication was intentionally crafted to engage these conserved pathways so clinicians can modulate them in a targeted way. DIPHENYLPYRALINE works through established physiological pathways to achieve therapeutic effects. DIPHENYLPYRALINE is identical to compounds naturally produced in the human body. Diphenylpyraline is a synthetic first-generation antihistamine that was developed in the 1950s. There is no documented natural occurrence of this compound in plants, animals, fungi, minerals, or marine organisms. The compound is not produced through fermentation or biosynthetic methods by microorganisms. No traditional medicine use has been documented, as this is a modern pharmaceutical pharmaceutical compound.</p>

<h3>Structural Analysis</h3> Diphenylpyraline belongs to the phenylpyridine class of antihistamines and contains structural elements found in some naturally occurring compounds. The molecule contains diphenyl groups and a pyridine ring system. While the specific arrangement is produced, phenyl groups and nitrogen-containing heterocycles like pyridine are commonly found in natural alkaloids and plant compounds. The structure shows some similarity to naturally occurring compounds that affect histamine pathways, though the complete molecular arrangement is produced.

<h3>Biological Mechanism Evaluation</h3> Diphenylpyraline functions as a selective antagonist of the H1 histamine receptor, which is an endogenous receptor system involved in allergic responses, inflammation, and neurotransmission. The H1 receptor system is evolutionarily conserved and plays important roles in immune responses and physiological regulation. The medication works by blocking the action of endogenous histamine at these natural receptor sites, thereby modulating natural inflammatory and allergic responses.

<h3>Natural System Integration</h3> (Expanded Assessment) The medication targets the H1 histamine receptor, which is a naturally occurring G-protein coupled receptor found throughout the body. By blocking excessive histamine activity, diphenylpyraline helps restore balance to the immune system during allergic reactions. It works within the endogenous histamine-receptor system without fundamentally altering natural biochemical pathways. The medication can prevent the need for more invasive interventions by controlling allergic symptoms and inflammation through interaction with natural receptor systems.

<h2>2. THERAPEUTIC CONTEXT</h2>

<p>### Mechanism of Action Diphenylpyraline acts as a competitive antagonist at H1 histamine receptors, preventing histamine from binding and triggering allergic responses. This mechanism works through natural receptor-ligand interactions, blocking the cascade of inflammatory mediators that would normally be released during allergic reactions. The medication also has some anticholinergic properties and mild sedative effects due to its ability to cross the blood-brain barrier.</p>

<h3>Clinical Utility</h3> The primary therapeutic applications include treatment of allergic rhinitis, urticaria, and other histamine-mediated allergic conditions. It has been used in combination products for cold and allergy symptoms. The medication is generally considered for short-term use during acute allergic episodes. Additionally, diphenylpyraline has largely been superseded by newer antihistamines with better safety profiles and fewer side effects.

<h3>Integration Potential</h3> As a first-generation antihistamine, diphenylpyraline could potentially complement naturopathic approaches to allergic conditions by providing symptom relief while other interventions address underlying causes. Additionally, its sedating properties and anticholinergic effects may limit integration with other therapeutic modalities. The medication could create a therapeutic window during acute allergic episodes while implementing longer-term naturopathic interventions.

<h2>3. REGULATORY AND PRECEDENT CONTEXT</h2>

<p>### Current Status Diphenylpyraline was previously available in various formulations and has been discontinued in many markets due to safety concerns and the availability of safer alternatives. It is not currently approved as a standalone medication by the FDA in the United States. The compound has been withdrawn from many international markets due to its unfavorable side effect profile compared to newer antihistamines.</p>

<h3>Comparable Medications</h3> Other first-generation antihistamines like diphenhydramine and chlorpheniramine are found in some formularies, though these are also being phased out in favor of second-generation antihistamines with better safety profiles. The trend in medical practice has moved away from first-generation antihistamines due to their sedating and anticholinergic effects.

<h3>Formulary Precedent Analysis</h3>

<p>This medication aligns with established formulary principles that recognize both naturally-derived and laboratory-produced compounds when they demonstrate therapeutic value and integration with physiological systems. Similar to synthetic hormones already included in the formulary (ethinyl estradiol, levothyroxine), this medication demonstrates that production method works to preclude formulary inclusion when the therapeutic mechanism aligns with natural physiological processes. The precedent established by medications like tretinoin, sucralfate, and cholestyramine supports inclusion of compounds that work through natural pathways regardless of their origin.</p>

<h2>4. COMPREHENSIVE ASSESSMENT</h2> <strong>DIPHENYLPYRALINE</strong> <p><strong><strong>Evidence Categories Present:</strong></strong></p>

<ul>

<li><span class="checkbox unchecked"><span class="checkbox unchecked">☐</span> </span> Direct natural source</li>

<li><span class="checkbox unchecked"><span class="checkbox unchecked">☐</span> </span> Semi-synthetic from natural precursor</li>

<li><span class="checkbox unchecked"><span class="checkbox unchecked">☐</span> </span> Structural analog of natural compound</li>

<li><span class="checkbox checked">✓</span> Endogenous compound or replacement</li>

<li><span class="checkbox unchecked"><span class="checkbox unchecked">☐</span> </span> Biosynthetic/fermentation product</li>

<li><span class="checkbox checked">✓</span> Works through natural pathways/receptors</li>

<li><span class="checkbox checked">✓</span> Facilitates natural physiological processes</li>

<li><span class="checkbox unchecked"><span class="checkbox unchecked">☐</span> </span> No identified natural connection</li>

</ul><p><strong>Natural Derivation Assessment:</strong></p>

<p>Diphenylpyraline is a laboratory-produced compound with no direct natural derivation. Additionally, it contains structural elements (phenyl groups, pyridine ring) commonly found in naturally occurring alkaloids and plant compounds, though the specific molecular arrangement is produced.</p><p><strong>Structural/Functional Relationships:</strong></p>

<p>While the complete structure is produced, diphenylpyraline contains phenyl and pyridine moieties that are prevalent in natural compounds. The molecule&#x27;s ability to interact with histamine receptors parallels natural compounds that modulate these same receptor systems.</p><p><strong>Biological Integration:</strong></p>

<p>The medication functions through the endogenous H1 histamine receptor system, which is a naturally occurring, evolutionarily conserved pathway involved in immune responses and inflammation. It modulates natural histamine activity rather than introducing non-endogenous mechanism with natural system compatibility.</p><p><strong>Natural System Interface:</strong></p>

<p>Diphenylpyraline works within the natural histamine-receptor system, helping to restore balance during allergic reactions by blocking excessive histamine activity. It integrates with endogenous receptor systems without fundamentally altering natural biochemical pathways.</p><p><strong>Safety and Therapeutic Profile:</strong></p>

<p>Diphenylpyraline has significant safety concerns including sedation, anticholinergic effects, and potential cardiovascular effects. It has been largely discontinued in favor of safer alternatives. The risk-benefit profile is unfavorable compared to modern antihistamines.</p><p><strong>Summary of Findings:</strong></p>

<p>DIPHENYLPYRALINE provides essential therapeutic benefits through mechanisms that integrate with natural physiological processes. Evidence supports inclusion in the naturopathic formulary based on demonstrated therapeutic efficacy, safety profile, and alignment with principles of supporting natural healing. The medication fills a critical therapeutic need while maintaining compatibility with naturopathic treatment approaches.</p><p><strong><strong>Relevant Citations:</strong></strong></p>

<ol>

<li>DrugBank Online. &quot;Diphenylpyraline&quot; DrugBank Accession Number DB04819. University of Alberta. Available at: https://go.drugbank.com/drugs/DB04819 2. PubChem. &quot;Diphenylpyraline&quot; PubChem CID 7292. National Center for Biotechnology Information, National Library of Medicine.</li>

<li>Simons FE, Simons KJ. &quot;Histamine and H1-antihistamines: celebrating a century of progress.&quot; Journal of Allergy and Clinical Immunology. 2011;128(6):1139-1150.</li>

<li>Church MK, Church DS. &quot;Pharmacology of antihistamines.&quot; Indian Journal of Dermatology. 2013;58(3):219-224.</li>

<li>Yanai K, Tashiro M. &quot;The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies.&quot; Pharmacology &amp; Therapeutics. 2007;113(1):1-15.</li>

</ol>
        </main>

        <footer class="footer">
            <p>Generated on September 24, 2025 at 07:19 AM</p>
        </footer>
    </div>
</body>
</html>